1. Home
  2. LGL vs PMN Comparison

LGL vs PMN Comparison

Compare LGL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

HOLD

Current Price

$5.75

Market Cap

34.1M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$9.34

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGL
PMN
Founded
1917
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LGL
PMN
Price
$5.75
$9.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
8.7K
43.4K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
149.85
N/A
EPS
0.17
N/A
Revenue
$4,107,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.45
$6.27
52 Week High
$9.74
$39.75

Technical Indicators

Market Signals
Indicator
LGL
PMN
Relative Strength Index (RSI) 43.89 89.39
Support Level $5.59 $7.35
Resistance Level $5.99 $9.26
Average True Range (ATR) 0.26 0.66
MACD -0.00 0.28
Stochastic Oscillator 50.00 99.12

Price Performance

Historical Comparison
LGL
PMN

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: